Crinetics – Talk Bio

Actionable Insights Powered by AI

Crinetics Reports Over $5M in Q4 2025 PALSONIFY Revenue with Strong Launch Metrics

3 weeks ago talkbio0Tagged Acromegaly, Crinetics, enrollment forms, methionine, PALSONIFY, prescribers, Q4 2025, Revenue

Crinetics; PALSONIFY; Palsonify; Q4 2025; revenue; $5M; acromegaly; enrollment forms; prescribers

Crinetics’s Atumelnant Shows Promising Early Results in Congenital Adrenal Hyperplasia Treatment

2 years ago talkbio0Tagged Adrenal Glands, Androgens, Atumelnant, Clinical Trials, Congenital adrenal hyperplasia, corticotropin, Crinetics, hydrocortisone

Crinetics, Atumelnant, congenital adrenal hyperplasia, early data, treatment, clinical trial, cortisol, androgens, ACTH, adrenal glands.

Crinetics’ Paltusotine Demonstrates Success in Second Phase III Trial for Oral Acromegaly Treatment, Prepares for FDA Filing

2 years ago talkbio0Tagged Acromegaly, Crinetics, Oral treatment, Paltusotine, Phase 3 Clinical Trials, Submission, Symptom reduction, United States Food and Drug Administration

Crinetics Pharmaceuticals, Paltusotine, Acromegaly, Phase III trials, FDA submission, Oral treatment, Symptom reduction